"Skulachev ions" against cataracts: Phase II trials
Clinical trials of a drug against another eye disease, glaucoma, also created on the basis of SkQ1 – "Skulachev ions" – began in Moscow clinics in September 2010.
19.11.2010Clinical trials of a drug against another eye disease, glaucoma, also created on the basis of SkQ1 – "Skulachev ions" – began in Moscow clinics in September 2010.
19.11.2010The conference "Postgenomic Technologies in Medicine: from theory to practice" will be held at Voronezh State University and the Medical University named after Burdenko on November 1 and 2.
20.10.2016Using a set of techniques, the authors found three types of opiate receptors (delta, kappa and mu) and two types of cannabinoid receptors (CB1 and CB2) on the surface of human spermatozoa. Moreover, receptors of all types are found on the head, middle part and tail of spermatozoa.
23.06.2008The Act prohibiting discrimination based on genetic data closes a black page in the history of the development of genetics and insurance medicine in the United States.
23.11.2009The NSimScan program works at the speed of the fastest analogs, significantly exceeding them in sensitivity and with a significantly reduced error rate.
31.03.2016Patients suffering from this disease develop obesity and have mental and behavioral problems. Scientists from the University of Manchester found out that the disease is associated with a deletion on the sixth chromosome.
04.02.2016Lecture by Maxim Skulachev, a leading researcher at the Faculty of Biology of Moscow State University, on whether it is possible to stop human aging and why the struggle for eternal youth has turned into a pursuit of technological progress.
09.12.2015The forum, which will last two days, is dedicated to discussing issues related to the development and production of innovative medicines in Russia.
17.11.2010The study of the effect of various physical exercises on the formation of new neurons has shown that the optimal load for enhancing neoneurogenesis in the hippocampus of rats is long-distance running.
17.02.2016A new method of gene therapy that attracts immune cells and "trains" them to destroy polymorphic glioma, ensures the formation of long-term antitumor immunity, does not cause side effects and, in the process of tumor destruction, stimulates the restoration of lost brain functions and behavioral skills.
27.02.2008Since 2018, geriatric medical care for elderly patients has been included in the rates of compulsory medical insurance.
11.01.2018The deterioration of physical condition in people with low levels of vitamin E in the blood occurred 1.62 times faster than in people with high levels of this vitamin.
29.01.2008The drug "FC Laboratories", a highly specific direct thrombin inhibitor, meets international standards and will be able to compete with foreign analogues.
07.12.2016With the help of the new system, the authors were able to correctly diagnose Parkinson's disease in 19 out of 20 cases and exclude the disease in all those who were healthy.
01.09.2016The surface of the chip, covered with microscopic needle structures, provides direct interaction of living cells with electronic devices.
30.11.2009The "smoking genes" that correlate most strongly with increased cravings for nicotine, the researchers considered certain gene variants of two membrane proteins of nerve cells – alpha-3 and alpha-5 subunits of the nicotine receptor. Now pharmacologists know the targets for new generation anti-nicotine drugs.
31.01.2008The AstraZeneca/MedImmune drug is now indicated for the treatment of non-small cell lung cancer.
20.02.2018During life, new collagen in cartilage is practically not formed even in people who are subjected to high physical exertion or have suffered some diseases.
20.07.2016The American company 23andMe, famous for DNA tests, plans to use its genome database in the independent development of drugs for various diseases.
16.03.2015Using computer modeling, scientists have created a compound that blocks HIV protease due to a fundamentally new mechanism.
26.05.2008You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.